• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TBX2通过外泌体介导的miR-200c-3p抑制驱动神经内分泌前列腺癌。

TBX2 Drives Neuroendocrine Prostate Cancer through Exosome-Mediated Repression of miR-200c-3p.

作者信息

Patel Girijesh Kumar, Dutta Sayanika, Syed Mosharaf Mahmud, Ramachandran Sabarish, Sharma Monica, Rajamanickam Venkatesh, Ganapathy Vadivel, DeGraff David J, Pruitt Kevin, Tripathi Manisha, Nandana Srinivas

机构信息

Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.

Department of Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.

出版信息

Cancers (Basel). 2021 Oct 7;13(19):5020. doi: 10.3390/cancers13195020.

DOI:10.3390/cancers13195020
PMID:34638504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8507954/
Abstract

Deciphering the mechanisms that drive transdifferentiation to neuroendocrine prostate cancer (NEPC) is crucial to identifying novel therapeutic strategies against this lethal and aggressive subtype of advanced prostate cancer (PCa). Further, the role played by exosomal microRNAs (miRs) in mediating signaling mechanisms that propagate the NEPC phenotype remains largely elusive. The unbiased differential miR expression profiling of human PCa cells genetically modulated for TBX2 expression led to the identification of miR-200c-3p. Our findings have unraveled the TBX2/miR-200c-3p/SOX2/N-MYC signaling axis in NEPC transdifferentiation. Mechanistically, we found that: (1) TBX2 binds to the promoter and represses the expression of miR-200c-3p, a miR reported to be lost in castrate resistant prostate cancer (CRPC), and (2) the repression of miR-200c-3p results in the increased expression of its targets SOX2 and N-MYC. In addition, the rescue of mir-200c-3p in the context of TBX2 blockade revealed that miR-200c-3p is the critical intermediary effector in TBX2 regulation of SOX2 and N-MYC. Further, our studies show that in addition to the intracellular mode, TBX2/miR-200c-3p/SOX2/N-MYC signaling can promote NEPC transdifferentiation via exosome-mediated intercellular mechanism, an increasingly recognized and key mode of propagation of the NEPC phenotype.

摘要

破译驱动向神经内分泌前列腺癌(NEPC)转分化的机制对于确定针对这种致命且侵袭性强的晚期前列腺癌(PCa)亚型的新治疗策略至关重要。此外,外泌体微小RNA(miR)在介导传播NEPC表型的信号机制中所起的作用在很大程度上仍不清楚。对经基因调控TBX2表达的人PCa细胞进行无偏倚的差异miR表达谱分析,鉴定出了miR-200c-3p。我们的研究结果揭示了NEPC转分化中的TBX2/miR-200c-3p/SOX2/N-MYC信号轴。从机制上讲,我们发现:(1)TBX2与启动子结合并抑制miR-200c-3p的表达,据报道该miR在去势抵抗性前列腺癌(CRPC)中缺失,以及(2)miR-200c-3p的抑制导致其靶标SOX2和N-MYC的表达增加。此外,在TBX2阻断的情况下挽救miR-200c-3p表明,miR-200c-3p是TBX2调节SOX2和N-MYC的关键中间效应因子。此外,我们的研究表明,除了细胞内模式外,TBX2/miR-200c-3p/SOX2/N-MYC信号还可以通过外泌体介导的细胞间机制促进NEPC转分化,这是一种越来越被认可的NEPC表型传播的关键模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/8507954/557c937f0283/cancers-13-05020-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/8507954/973f27218533/cancers-13-05020-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/8507954/673432f9a004/cancers-13-05020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/8507954/47d0beb6fec9/cancers-13-05020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/8507954/75b46ccca8f7/cancers-13-05020-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/8507954/c117f5570706/cancers-13-05020-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/8507954/557c937f0283/cancers-13-05020-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/8507954/973f27218533/cancers-13-05020-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/8507954/673432f9a004/cancers-13-05020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/8507954/47d0beb6fec9/cancers-13-05020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/8507954/75b46ccca8f7/cancers-13-05020-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/8507954/c117f5570706/cancers-13-05020-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/725e/8507954/557c937f0283/cancers-13-05020-g006.jpg

相似文献

1
TBX2 Drives Neuroendocrine Prostate Cancer through Exosome-Mediated Repression of miR-200c-3p.TBX2通过外泌体介导的miR-200c-3p抑制驱动神经内分泌前列腺癌。
Cancers (Basel). 2021 Oct 7;13(19):5020. doi: 10.3390/cancers13195020.
2
Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer.miR-200b-3p/200c-3p 和 XBP1 对人前列腺癌细胞中 PRKAR2B 的转录调控
Biomed Pharmacother. 2020 Apr;124:109863. doi: 10.1016/j.biopha.2020.109863. Epub 2020 Jan 24.
3
Bile-derived exosome noncoding RNAs as potential diagnostic and prognostic biomarkers for cholangiocarcinoma.胆汁衍生的外泌体非编码RNA作为胆管癌潜在的诊断和预后生物标志物。
Front Oncol. 2022 Aug 24;12:985089. doi: 10.3389/fonc.2022.985089. eCollection 2022.
4
MiR-200c-3p Contrasts PD-L1 Induction by Combinatorial Therapies and Slows Proliferation of Epithelial Ovarian Cancer through Downregulation of β-Catenin and c-Myc.miR-200c-3p 通过下调β-连环蛋白和 c-Myc 对比联合治疗诱导的 PD-L1 表达并减缓上皮性卵巢癌细胞增殖。
Cells. 2021 Mar 1;10(3):519. doi: 10.3390/cells10030519.
5
miR-200c-3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment.miR-200c-3p 在人口腔鳞状细胞癌微环境中传播侵袭能力。
Mol Carcinog. 2018 Feb;57(2):295-302. doi: 10.1002/mc.22744. Epub 2017 Oct 31.
6
LIN28B promotes the development of neuroendocrine prostate cancer.LIN28B 促进神经内分泌前列腺癌的发展。
J Clin Invest. 2020 Oct 1;130(10):5338-5348. doi: 10.1172/JCI135373.
7
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process.在表皮生长因子受体(EGFR)突变的非小细胞肺癌中,miR-200c-3p的抑制与通过介导上皮-间质转化(EMT)过程产生对EGFR酪氨酸激酶抑制剂的获得性耐药相关。
Cancer Biomark. 2020;28(3):351-363. doi: 10.3233/CBM-191119.
8
miRNA-200c-3p targets talin-1 to regulate integrin-mediated cell adhesion.miRNA-200c-3p 通过靶向 talin-1 调节整合素介导的细胞黏附。
Sci Rep. 2021 Nov 3;11(1):21597. doi: 10.1038/s41598-021-01143-3.
9
Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8.抗磷脂抗体诱导的miR-146a-3p通过激活Toll样受体8驱动滋养层细胞白细胞介素-8分泌。
Mol Hum Reprod. 2016 Jul;22(7):465-74. doi: 10.1093/molehr/gaw027. Epub 2016 Mar 29.
10
..
Cancer Cell Int. 2018 Jan 3;18:2. doi: 10.1186/s12935-017-0500-0. eCollection 2018.

引用本文的文献

1
The role of SOX transcription factors in prostate cancer: Focusing on SOX2.SOX转录因子在前列腺癌中的作用:聚焦于SOX2
Genes Dis. 2025 May 21;12(6):101692. doi: 10.1016/j.gendis.2025.101692. eCollection 2025 Nov.
2
New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to Clinic.神经内分泌前列腺癌潜在治疗靶点的新见解:从实验室到临床
Research (Wash D C). 2025 Jul 31;8:0791. doi: 10.34133/research.0791. eCollection 2025.
3
NFIC suppressed the epithelial ovarian cancer via modulating the balance of PTEN/TGFβ1/EGR1/BRD4 and SP1/EZH2 induced Inhibition of TBX2/MMPs signaling.

本文引用的文献

1
Small extracellular vesicles modulated by αVβ3 integrin induce neuroendocrine differentiation in recipient cancer cells.由αVβ3整合素调节的小细胞外囊泡诱导受体癌细胞发生神经内分泌分化。
J Extracell Vesicles. 2020 May 24;9(1):1761072. doi: 10.1080/20013078.2020.1761072.
2
miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology.miRNet 2.0:基于网络的 miRNA 功能分析和系统生物学的可视化分析。
Nucleic Acids Res. 2020 Jul 2;48(W1):W244-W251. doi: 10.1093/nar/gkaa467.
3
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation.
核因子I/C(NFIC)通过调节PTEN/TGFβ1/早期生长反应蛋白1(EGR1)/溴结构域蛋白4(BRD4)的平衡以及SP1/增强子结合蛋白2(EZH2)诱导的T-框蛋白2(TBX2)/基质金属蛋白酶(MMPs)信号传导抑制来抑制上皮性卵巢癌。
Sci Rep. 2025 Jul 22;15(1):26593. doi: 10.1038/s41598-025-09653-0.
4
Widespread activation and critical role of EMT and stemness in the neuroendocrine differentiation of prostate cancer (Review).上皮-间质转化(EMT)和干性在前列腺癌神经内分泌分化中的广泛激活及关键作用(综述)
Oncol Rep. 2025 Sep;54(3). doi: 10.3892/or.2025.8942. Epub 2025 Jul 11.
5
A TBX2-driven signaling switch from androgen receptor to glucocorticoid receptor confers therapeutic resistance in prostate cancer.由TBX2驱动的从雄激素受体到糖皮质激素受体的信号转导开关赋予前列腺癌治疗抗性。
Oncogene. 2025 Apr;44(13):877-892. doi: 10.1038/s41388-024-03252-5. Epub 2024 Dec 20.
6
Role of non-coding RNA in lineage plasticity of prostate cancer.非编码RNA在前列腺癌谱系可塑性中的作用。
Cancer Gene Ther. 2025 Jan;32(1):1-10. doi: 10.1038/s41417-024-00834-z. Epub 2024 Nov 4.
7
The biological function of extracellular vesicles in prostate cancer and their clinical application as diagnostic and prognostic biomarkers.细胞外囊泡在前列腺癌中的生物学功能及其作为诊断和预后生物标志物的临床应用。
Cancer Metastasis Rev. 2024 Dec;43(4):1611-1627. doi: 10.1007/s10555-024-10210-w. Epub 2024 Sep 24.
8
PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma.PRADclass:基于 Gleason 分级信息的混合计算策略鉴定预测侵袭性前列腺腺癌的共识生物标志物特征
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338231222389. doi: 10.1177/15330338231222389.
9
The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer.ELAVL3/MYCN 正反馈回路为神经内分泌前列腺癌提供了治疗靶点。
Nat Commun. 2023 Nov 28;14(1):7794. doi: 10.1038/s41467-023-43676-3.
10
Editorial: Molecular drivers of prostate cancer pathogenesis and therapy resistance.社论:前列腺癌发病机制和治疗耐药性的分子驱动因素
Front Cell Dev Biol. 2023 Jun 23;11:1239478. doi: 10.3389/fcell.2023.1239478. eCollection 2023.
CHD1 缺失通过染色质失调促进 AR 靶向治疗耐药的异质性机制。
Cancer Cell. 2020 Apr 13;37(4):584-598.e11. doi: 10.1016/j.ccell.2020.03.001. Epub 2020 Mar 26.
4
The biology function and biomedical applications of exosomes.外泌体的生物学功能和生物医学应用。
Science. 2020 Feb 7;367(6478). doi: 10.1126/science.aau6977.
5
Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer.miR-200b-3p/200c-3p 和 XBP1 对人前列腺癌细胞中 PRKAR2B 的转录调控
Biomed Pharmacother. 2020 Apr;124:109863. doi: 10.1016/j.biopha.2020.109863. Epub 2020 Jan 24.
6
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.MUC1-C 调控谱系可塑性,促进神经内分泌前列腺癌的进展。
Nat Commun. 2020 Jan 17;11(1):338. doi: 10.1038/s41467-019-14219-6.
7
Bioinformatics analyses of publicly available NEPCa datasets.对公开可用的神经内分泌前列腺癌(NEPCa)数据集进行生物信息学分析。
Am J Clin Exp Urol. 2019 Oct 15;7(5):327-340. eCollection 2019.
8
Acetylation of conserved DVL-1 lysines regulates its nuclear translocation and binding to gene promoters in triple-negative breast cancer.乙酰化的保守 DVL-1 赖氨酸调节其在三阴性乳腺癌中的核转位和与基因启动子的结合。
Sci Rep. 2019 Nov 7;9(1):16257. doi: 10.1038/s41598-019-52723-3.
9
The paracrine induction of prostate cancer progression by caveolin-1.小窝蛋白-1 旁分泌诱导前列腺癌进展。
Cell Death Dis. 2019 Nov 4;10(11):834. doi: 10.1038/s41419-019-2066-3.
10
Towards precision oncology in advanced prostate cancer.迈向晚期前列腺癌的精准肿瘤学。
Nat Rev Urol. 2019 Nov;16(11):645-654. doi: 10.1038/s41585-019-0237-8. Epub 2019 Oct 7.